27 February 2025 Former Latham & Watkins global vice chair joins the firm as co-chair of its technology transactions practice ...

Concerns over misuse, side effects and counterfeits are tightening controls on the blockbuster treatments, says Iona ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

A game-changer for UPC tech disputes ...

Former Latham & Watkins global vice chair joins the firm as co-chair of its technology transactions practice | New partner ...

Delaware federal judge reverses jury verdict in CareDx’s favour | Natera’s patents covering organ transplant testing ...

The company’s nine-country ban against a Chinese rival saw the court adopt a broad interpretation of means-plus-function ...

In Wuhan Healthgen Biotech v ITC, the Federal Circuit affirmed the US International Trade Commission’s (ITC) conclusion that ...

British pharma giant says that a Federal Circuit decision could stifle competition by lowering the bar for proving patent ...

David Por joins the firm’s Paris team as partner | New hire brings two decades of experience, including in healthcare and ...

The former USPTO director has filed her first amicus brief since rejoining private practice, arguing that instructions issued ...